SPAC25B8.20 Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to SPAC25B8.20 Antibody

SPAC25B8.20 antibody is a specialized research reagent designed for the detection and study of the SPAC25B8.20 protein in Schizosaccharomyces pombe (fission yeast). This antibody represents a crucial tool in molecular biology research, particularly for scientists investigating protein functions and cellular processes in this important model organism. S. pombe has emerged as a powerful platform for studying eukaryotic gene function due to its relative simplicity, well-annotated genome, and genetic tractability under controlled laboratory conditions . The fission yeast genome contains 5,134 protein-coding genes, with approximately 70.6% conserved in metazoa, making it an excellent model for understanding fundamental cellular processes relevant to human biology .

SPAC25B8.20 antibody, available through specialized suppliers like Cusabio, has been developed specifically to recognize and bind to the SPAC25B8.20 protein with high specificity and affinity. The availability of this research tool enables scientists to investigate the expression, localization, and function of this protein within the broader context of fission yeast biology and comparative genomics studies.

Research Context and Applications in Fission Yeast Studies

Schizosaccharomyces pombe serves as an excellent model organism for studying eukaryotic cellular processes. Unlike budding yeast, fission yeast does not undergo genome duplication, resulting in less gene redundancy and a higher likelihood that mutations will produce observable phenotypes . This characteristic makes it particularly valuable for functional genomics studies.

The application of SPAC25B8.20 antibody must be understood within the broader context of fission yeast research. Recent comprehensive studies have employed phenomics and machine-learning approaches to characterize protein functions in S. pombe. For instance, researchers have conducted extensive phenotyping of genome-wide deletion mutants, including observations of colony-growth phenotypes for 3,509 non-essential genes across 131 different environmental conditions . Such studies have generated rich datasets that provide insights into protein functions and their relationships.

Methodology for Antibody Application in Fission Yeast Research

SPAC25B8.20 antibody can be effectively utilized in several experimental procedures when studying fission yeast proteins. The primary applications include:

Western Blotting Protocol

Western blotting represents one of the main applications for this antibody, allowing researchers to detect and quantify the SPAC25B8.20 protein in cell lysates. The recommended protocol involves:

  1. Sample preparation from fission yeast cultures grown in appropriate media such as YES (Yeast Extract with Supplements) or EMM (Edinburgh Minimal Medium)

  2. Protein extraction and separation using SDS-PAGE

  3. Transfer to appropriate membrane

  4. Blocking and incubation with SPAC25B8.20 antibody (typically at 1:1000 dilution)

  5. Detection using appropriate secondary antibodies and visualization systems

ELISA Applications

The antibody is also validated for ELISA applications, providing an alternative method for protein detection and quantification. This methodology is particularly useful when quantitative measurements are required.

Potential Research Applications and Future Directions

The SPAC25B8.20 antibody represents an important tool for investigating protein function within the broader context of fission yeast biology. While specific studies utilizing this antibody are not extensively documented in the current literature, it holds significant potential for advancing research in several areas:

Functional Genomics Studies

The antibody can contribute to functional genomics approaches aimed at characterizing the role of SPAC25B8.20 protein. Recent research has demonstrated that comprehensive phenotyping of deletion mutants can provide valuable insights into protein functions . By allowing researchers to detect and quantify the SPAC25B8.20 protein, this antibody facilitates investigations into how the presence, absence, or modification of this protein affects cellular processes.

Stress Response Investigations

Fission yeast has emerged as an important model for studying cellular responses to environmental stresses. Previous studies have characterized transcriptional responses to various stressors, including oxidative stress, heavy metal stress, heat shock, osmotic stress, and DNA damage . The SPAC25B8.20 antibody could potentially be used to investigate whether this protein plays a role in these stress response pathways.

Protein Interaction Studies

Understanding protein interactions is crucial for elucidating cellular pathways. The SPAC25B8.20 antibody may be valuable for co-immunoprecipitation experiments aimed at identifying interaction partners of the SPAC25B8.20 protein, potentially revealing its role in cellular signaling networks or structural complexes.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SPAC25B8.20 antibody; Uncharacterized protein C25B8.20 antibody
Target Names
SPAC25B8.20
Uniprot No.

Q&A

What is the SPAC25B8.20 protein in Schizosaccharomyces pombe and why is it significant for research?

The SPAC25B8.20 protein is a specific protein encoded in the S. pombe genome, which contains approximately 5,134 protein-coding genes. S. pombe has emerged as a powerful model organism with about 70.6% of its genes conserved in metazoa, making it valuable for understanding fundamental cellular processes relevant to human biology.

Unlike budding yeast, S. pombe doesn't undergo genome duplication, resulting in less gene redundancy. This characteristic means mutations are more likely to produce observable phenotypes, making it particularly valuable for functional genomics studies. The SPAC25B8.20 antibody enables researchers to investigate this protein's expression, localization, and function within the broader context of fission yeast biology and comparative genomics.

What buffer conditions are optimal for preserving SPAC25B8.20 antibody activity?

The SPAC25B8.20 antibody is typically provided in a buffer containing 0.03% Proclin 300 as a preservative, with constituents including 50% Glycerol and 0.01M Phosphate Buffered Saline. This formulation helps maintain antibody stability and activity during storage.

For optimal preservation of activity:

  • Maintain storage temperature at -20°C for long-term storage

  • Avoid repeated freeze-thaw cycles by aliquoting the antibody upon receipt

  • When diluting for experiments, use buffers with neutral pH (6.8-7.4)

  • If adding additional preservatives, avoid sodium azide when working with HRP-conjugated antibodies as it inhibits peroxidase activity

How do I validate the specificity of SPAC25B8.20 antibody in my experiments?

Validating antibody specificity is crucial for ensuring reliable results. For SPAC25B8.20 antibody, implement these methodological approaches:

  • Knockout/knockdown controls: Compare staining between wild-type S. pombe and strains with SPAC25B8.20 gene deletion or knockdown

  • Competing peptide assay: Pre-incubate the antibody with purified SPAC25B8.20 protein or peptide before application to samples

  • Western blot analysis: Confirm single band at expected molecular weight

  • Immunoprecipitation followed by mass spectrometry: Similar to the approach used to validate Abs-9 antibody against SpA5, where ultrasonic fragmentation and centrifugation of bacterial fluid was followed by co-incubation with the antibody, protein A bead binding, and mass spectrometry detection of eluate

How can I optimize SPAC25B8.20 antibody concentration for immunofluorescence in S. pombe cells with varying expression levels?

Optimizing antibody concentration requires a methodical approach:

  • Titration experiments: Perform a dilution series (1:100, 1:250, 1:500, 1:1000, 1:2500) to identify optimal signal-to-noise ratio

  • Expression level stratification: For heterogeneous populations:

    • Start with cell synchronization to normalize expression if cell-cycle dependent

    • Use a pre-titrated concentration (e.g., 5 μL per test where a test equals 100 μL final volume) as a starting point, similar to CD20 antibody optimization

    • Empirically determine cell number (10^5-10^8 cells/test) based on expected expression level

  • Signal amplification strategies: For low expression proteins:

    • Implement tyramide signal amplification

    • Use high-sensitivity detection systems

    • Extend primary antibody incubation time (overnight at 4°C)

What approaches can address non-specific binding when using SPAC25B8.20 antibody in immunoprecipitation experiments?

Non-specific binding can compromise experimental results. Address this methodologically:

  • Optimized blocking:

    • Test multiple blocking agents (BSA, milk, normal serum, commercial blockers)

    • Extend blocking time to 2 hours at room temperature

    • Include 0.1-0.3% Triton X-100 in blocking buffer to reduce hydrophobic interactions

  • Pre-clearing lysates:

    • Incubate lysates with beads alone before adding antibody

    • Use species-matched control IgG with beads

    • Centrifuge lysates at high speed (20,000 × g, 15 min) before immunoprecipitation

  • Stringent washing:

    • Implement gradient washing with increasing salt concentration (150mM to 300mM NaCl)

    • Include 0.1% SDS or 0.1% deoxycholate in later washes

    • Perform additional wash steps (5-6 washes instead of standard 3)

  • Antibody crosslinking:

    • Chemically crosslink antibody to beads to prevent co-elution

    • Use a two-step elution approach with increasing stringency

How can I distinguish between specific and non-specific signals when using SPAC25B8.20 antibody across multiple S. pombe strains?

When working with multiple strains, implement these methodological controls:

  • Strain-specific validation panel:

    • Include SPAC25B8.20 deletion strain as negative control

    • Use strain with GFP/epitope-tagged SPAC25B8.20 as positive control

    • Include wild-type strain for baseline expression

  • Signal normalization approach:

    • Apply dual-labeling with housekeeping protein antibody

    • Implement ratio-based quantification (SPAC25B8.20/housekeeping protein)

    • Use statistical analysis to determine significance thresholds

  • Signal characterization:

    • Compare subcellular localization patterns across strains

    • Analyze molecular weight consistency on western blots

    • Perform peptide competition assays for each strain

  • Sequential antibody application:

    • Apply secondary antibody alone to detect non-specific binding

    • Use isotype control antibody to identify Fc receptor binding

    • Perform blocking peptide gradients to establish specificity thresholds

How can I integrate SPAC25B8.20 antibody-based studies with high-throughput single-cell RNA sequencing for comprehensive protein-expression correlation?

Integration of antibody-based detection with transcriptomics requires sophisticated methodology:

  • Cell preparation protocol:

    • Optimize gentle cell wall digestion maintaining epitope integrity

    • Develop fixation method compatible with both techniques

    • Establish single-cell isolation protocol minimizing stress response

  • Integrated workflow:

    • Apply a modified CITE-seq approach adapting methods from B-cell studies:

      • Conjugate SPAC25B8.20 antibody with DNA barcodes

      • Perform antibody staining followed by cell lysis

      • Capture both mRNA and antibody-derived tags

    • Similar to high-throughput single-cell RNA and VDJ sequencing used for memory B cells in SpA5 antibody development

  • Data integration framework:

    • Develop computational pipeline correlating protein levels with transcript abundance

    • Implement trajectory analysis for temporal protein-RNA relationships

    • Apply machine learning clustering similar to approaches used in phenomics studies of S. pombe

  • Validation experiments:

    • Select key populations for protein quantification by flow cytometry

    • Perform targeted RT-PCR for transcript validation

    • Use in situ hybridization combined with immunofluorescence for spatial confirmation

What methodological modifications are necessary when using SPAC25B8.20 antibody for studying protein interactions under stress conditions?

Studying protein-protein interactions under stress requires specialized approaches:

  • Stabilization strategies:

    • Implement in vivo crosslinking before cell lysis (1% formaldehyde, 10 min)

    • Use specialized lysis buffers containing interaction stabilizers

    • Perform rapid immunoprecipitation at stress-relevant temperatures

  • Stress application protocols:

    • Design temporal stress application (acute vs. chronic)

    • Establish appropriate controls for stress-specific vs. general stress responses

    • Create recovery time series experiments

  • Advanced interaction detection:

    • Apply proximity ligation assay for spatial interaction verification

    • Implement BioID or APEX2 proximity labeling with SPAC25B8.20 as bait

    • Use quantitative mass spectrometry for interaction partner identification

  • Data analysis framework:

    • Develop interaction network visualization tools

    • Apply statistical methods for determining stress-specific interactions

    • Implement comparative analysis across stress types

How should I design experiments to compare SPAC25B8.20 antibody performance against genetic tagging approaches?

A comprehensive comparison requires systematic experimental design:

ApproachSensitivitySpecificityTemporal ResolutionSpatial ResolutionLive Cell Compatibility
SPAC25B8.20 AntibodyHigh (with amplification)Variable (requires validation)Fixed timepointsSubcellularNo
GFP TaggingModerateHighContinuousSubcellularYes
Epitope TaggingHighVery HighFixed timepointsSubcellularNo
Mass SpecVery HighHighFixed timepointsOrganelle levelNo

Methodology for comparison:

  • Parallel processing workflow:

    • Create strains with tagged SPAC25B8.20 (GFP, HA, etc.)

    • Process identical samples with antibody and tag detection

    • Apply standardized quantification metrics

  • Multi-parameter assessment:

    • Evaluate detection threshold (minimum detectable protein)

    • Measure dynamic range of quantification

    • Assess impact on protein localization and function

    • Determine compatibility with downstream applications

  • Validation experiments:

    • Confirm co-localization between antibody and tag signals

    • Perform quantitative correlation analysis

    • Test detection consistency across growth conditions

What methodological approaches can resolve contradictory results between SPAC25B8.20 antibody-based protein detection and transcript level measurements?

Resolving protein-transcript discrepancies requires systematic investigation:

  • Technical validation protocol:

    • Verify antibody specificity using methods described in question 1.3

    • Confirm transcript detection by multiple primer sets/probes

    • Assess for technical artifacts in both methods

  • Biological mechanism investigation:

    • Examine protein stability through cycloheximide chase experiments

    • Measure protein half-life using time-course analysis

    • Investigate post-transcriptional regulation mechanisms

    • Analyze potential alternative splicing events

  • Advanced quantitative approaches:

    • Implement absolute quantification of both protein and mRNA

    • Perform single-cell analysis to identify subpopulations

    • Design pulse-chase experiments to measure synthesis vs. degradation rates

    • Conduct temporal correlation analysis with appropriate time shifts

  • Integrative data analysis:

    • Apply mathematical modeling to identify regulation parameters

    • Implement statistical approaches accounting for temporal delays

    • Develop visualization tools for protein-transcript relationships

How can SPAC25B8.20 antibody be used to investigate protein degradation dynamics similar to studies performed with CD20 antibodies?

SPAC25B8.20 antibody can be adapted for protein degradation studies using methods inspired by CD20 antibody research:

  • Pulse-chase experimental design:

    • Label cells with 35S-methionine

    • Chase with cold methionine at defined timepoints

    • Immunoprecipitate SPAC25B8.20 at each timepoint

    • Quantify by autoradiography or phosphorimaging

  • Proteasome inhibition studies:

    • Treat cells with proteasome inhibitors (MG132)

    • Perform western blots with SPAC25B8.20 antibody

    • Quantify protein accumulation over time

    • Similar to approaches used in studying CD20 degradation dynamics

  • Ubiquitination analysis workflow:

    • Perform SPAC25B8.20 immunoprecipitation under denaturing conditions

    • Probe with anti-ubiquitin antibodies

    • Analyze ubiquitination pattern changes under various conditions

    • Identify potential E3 ligases through genetic screening

  • Degradation pathway investigation:

    • Compare effects of inhibitors targeting different degradation pathways

    • Analyze SPAC25B8.20 localization during degradation

    • Track protein fragments using domain-specific antibodies

    • Implement fluorescence-based degradation reporters

What are the optimal methods for using SPAC25B8.20 antibody in studying protein-protein interactions through co-immunoprecipitation studies?

For robust protein-protein interaction studies:

  • Cell lysis optimization:

    • Test multiple lysis buffers varying in stringency:

      • Low stringency: 150mM NaCl, 1% NP-40, 50mM Tris pH 7.5

      • Medium stringency: Add 0.1% SDS or 0.5% deoxycholate

      • High stringency: Increase to 300mM NaCl with 0.5% SDS

    • Determine optimal buffer maintaining interactions while reducing background

  • Immunoprecipitation strategy:

    • Compare direct antibody coupling vs. protein A/G beads

    • Optimize antibody concentration (typically 1-5 μg per 500 μg protein lysate)

    • Determine ideal incubation conditions (4°C overnight vs. room temperature 2 hours)

    • Implement chemical crosslinking to stabilize transient interactions

  • Validation approach:

    • Perform reciprocal co-IPs with antibodies against interacting partners

    • Include size exclusion chromatography to verify complex formation

    • Apply proximity-based assays (PLA, FRET) for in vivo confirmation

    • Conduct mass spectrometry analysis for unbiased interaction discovery, similar to the approach used for SpA5 antibody

  • Controls and data analysis:

    • Include IgG isotype controls matched to SPAC25B8.20 antibody

    • Perform interaction resistance tests (salt, detergent sensitivity)

    • Apply quantitative analysis normalizing to input levels

    • Implement statistical analysis for determining significance

How can researchers address epitope masking issues when working with SPAC25B8.20 antibody in different experimental contexts?

Epitope masking can occur due to protein-protein interactions, conformational changes, or post-translational modifications. Address methodologically:

  • Epitope accessibility enhancement techniques:

    • Test multiple fixation protocols:

      • Formaldehyde (0.5-4%, 10-30 minutes)

      • Methanol (-20°C, 5-15 minutes)

      • Acetone (-20°C, 5-10 minutes)

    • Apply epitope retrieval methods:

      • Heat-induced (95-100°C, 10-30 minutes in citrate buffer pH 6.0)

      • Protease-induced (trypsin or proteinase K, carefully titrated)

      • Detergent treatment (0.1-0.5% SDS, 5 minutes)

  • Sample preparation optimization:

    • Vary lysis conditions to disrupt masking interactions

    • Test denaturing vs. native conditions

    • Apply chaotropic agents at low concentrations

    • Implement sequential extraction procedures

  • Alternative detection strategies:

    • Target different epitopes using multiple antibodies

    • Apply antibody cocktails for enhanced detection

    • Develop proximity probes for conformationally obscured epitopes

    • Implement signal amplification systems

  • Special cases handling:

    • For phosphorylation-dependent epitope masking:

      • Include phosphatase treatment controls

      • Use phosphorylation-specific antibodies

    • For complex-dependent masking:

      • Apply mild dissociation conditions

      • Implement cross-linking followed by epitope exposure

What computational approaches can help analyze complex datasets generated using SPAC25B8.20 antibody in high-content imaging experiments?

High-content imaging generates complex multi-dimensional data requiring sophisticated analytical approaches:

  • Image preprocessing pipeline:

    • Implement flat-field correction for illumination normalization

    • Apply deconvolution algorithms for improved resolution

    • Develop automated segmentation for cell/organelle identification

    • Establish quality control metrics for image inclusion/exclusion

  • Feature extraction framework:

    • Extract morphological parameters (size, shape, texture)

    • Measure intensity parameters (total, mean, integrated density)

    • Analyze spatial distribution parameters (clustering, polarization)

    • Implement co-localization analysis with reference markers

  • Machine learning approach:

    • Apply unsupervised clustering to identify phenotypic subpopulations

    • Implement supervised classification for condition identification

    • Develop deep learning algorithms for feature detection

    • Use dimensionality reduction techniques for visualization

  • Statistical analysis strategy:

    • Implement mixed-effects models for population/subpopulation analysis

    • Apply time-series analysis for dynamic studies

    • Develop spatial statistics for distribution pattern analysis

    • Implement bootstrapping approaches for robust estimation

  • Integration with other data types:

    • Correlate imaging data with transcriptomics

    • Develop multimodal data fusion approaches

    • Implement network analysis for pathway identification

    • Similar to approaches used in S. pombe phenomics studies

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.